171 related articles for article (PubMed ID: 1677041)
1. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus.
Napier TC; Simson PE; Givens BS
J Pharmacol Exp Ther; 1991 Jul; 258(1):249-62. PubMed ID: 1677041
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists.
Napier TC
Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111
[TBL] [Abstract][Full Text] [Related]
3. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
[TBL] [Abstract][Full Text] [Related]
4. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine.
Heidenreich BA; Mailman RB; Nichols DE; Napier TC
J Pharmacol Exp Ther; 1995 Apr; 273(1):516-25. PubMed ID: 7714807
[TBL] [Abstract][Full Text] [Related]
5. Systemic and microiontophoretic administration of morphine differentially effect ventral pallidum/substantia innominata neuronal activity.
Napier TC; Chrobak JJ; Yew J
Synapse; 1992 Nov; 12(3):214-9. PubMed ID: 1481140
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
Napier TC; Maslowski-Cobuzzi RJ
Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.
Maslowski RJ; Napier TC
Eur J Pharmacol; 1991 Jul; 200(1):103-12. PubMed ID: 1685119
[TBL] [Abstract][Full Text] [Related]
8. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
Jeziorski M; White FJ
Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
[TBL] [Abstract][Full Text] [Related]
9. In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizocilpine, and ketamine anesthesia.
Kelland MD; Soltis RP; Anderson LA; Bergstrom DA; Walters JR
Synapse; 1995 Aug; 20(4):338-50. PubMed ID: 7482293
[TBL] [Abstract][Full Text] [Related]
10. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
Carlson JH; Bergstrom DA; Demo SD; Walters JR
Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
[TBL] [Abstract][Full Text] [Related]
11. Effects of D1 and D2 antagonists on apomorphine-induced responses of ventral pallidal neurons.
Maslowski RJ; Napier TC
Neuroreport; 1991 Aug; 2(8):451-4. PubMed ID: 1832988
[TBL] [Abstract][Full Text] [Related]
12. Effects of apomorphine and β-carbolines on firing rate of neurons in the ventral pallidum in the rats.
Haghparast A; Farzin D; Ordikhani-Seyedlar M; Motaman S; Kermani M; Azizi P
Behav Brain Res; 2012 Feb; 227(1):109-15. PubMed ID: 22074900
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
[TBL] [Abstract][Full Text] [Related]
14. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
Turner MS; Gray TS; Mickiewicz AL; Napier TC
Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
[TBL] [Abstract][Full Text] [Related]
15. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
Lee CR; Abercrombie ED; Tepper JM
Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
17. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
[TBL] [Abstract][Full Text] [Related]
18. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
[TBL] [Abstract][Full Text] [Related]
19. Molecular, chemical, and anatomical characterization of globus pallidus dopamine D2 receptor mRNA-containing neurons.
Hoover BR; Marshall JF
Synapse; 2004 May; 52(2):100-13. PubMed ID: 15034916
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of cocaine on firing rate and pattern of dopamine neurons: role of alpha1 receptors and comparison with L-dopa and apomorphine.
Zhou Y; Bunney BS; Shi WX
J Pharmacol Exp Ther; 2006 Apr; 317(1):196-201. PubMed ID: 16330495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
